sapropterin dihydrochloride 100 MG Powder for Oral Solution
- RxCUI
- 1111018
- RxNorm name
- sapropterin dihydrochloride 100 MG Powder for Oral Solution
- Display name
- sapropterin dihydrochloride 100 MG Powder for Oral Solution
- Full name
- sapropterin dihydrochloride 100 MG Powder for Oral Solution
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:16
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sapropterin dihydrochloride | SAPROPTERIN DIHYDROCHLORIDE | Camber Pharmaceuticals, Inc. | 3f0d6820-ff59-40c0-882f-aeea2dd1d1ad | 2026-03-05 | Warnings, Adverse reactions | 1111018 |
| Sapropterin Dihydrochloride | SAPROPTERIN DIHYDROCHLORIDE | TRUPHARMA, LLC | 39f1d020-4359-401b-88a8-ed25eaa40b45 | 2026-02-18 | Warnings, Adverse reactions | 1111018 |
| Sapropterin Dihydrochloride | SAPROPTERIN DIHYDROCHLORIDE | Micro Labs Limited | 907e24c4-3337-4aee-b789-276e37a85cd8 | 2026-01-14 | Warnings, Adverse reactions | 1111018 |
| ZELVYSIA | SAPROPTERIN DIHYDROCHLORIDE | Aucta Pharmaceuticals, Inc. | 8de84882-dd24-46f2-8416-5e492d4275d1 | 2025-04-30 | Warnings, Adverse reactions | 1111018 |
| JAVYGTOR | SAPROPTERIN DIHYDROCHLORIDE | Dr. Reddys Laboratories Inc | 1590afa1-baa4-70e5-5a3b-468401c71044 | 2024-10-21 | Warnings, Adverse reactions | 1111018 |
| Kuvan | SAPROPTERIN DIHYDROCHLORIDE | BioMarin Pharmaceutical Inc. | af38711e-8873-4790-a92d-4d583e23fb89 | 2024-08-26 | Warnings, Adverse reactions | 1111018 |
| Sapropterin dihydrochloride | SAPROPTERIN DIHYDROCHLORIDE | NorthStar RxLLC | b3999f74-920d-4444-afa7-f4211e4eb431 | 2024-07-09 | Warnings, Adverse reactions | 1111018 |
| SAPROPTERIN DIHYDROCHLORIDE | SAPROPTERIN DIHYDROCHLORIDE | Par Health USA, LLC | 6b2172e4-42fc-42fe-b1ad-9d6a974d4343 | 2020-07-09 | Warnings, Adverse reactions | 1111018 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| af38711e-8873-4790-a92d-4d583e23fb89 | sapropterin dihydrochloride 100 MG Powder for Oral Solution [PSN] · sapropterin dihydrochloride 100 MG Powder for Oral Solution [SCD] | 2 | 79 | These highlights do not include all the information needed to use KUVAN safely and effectively. See full prescribing information for KUVAN. KUVAN (sapropterin dihydrochloride) tablets, for oral use KUVAN (sapropterin dihydrochloride) powder, for oral solution Initial U.S. Approval: 2007 | 20240826 |
| 6b2172e4-42fc-42fe-b1ad-9d6a974d4343 | sapropterin dihydrochloride 100 MG Powder for Oral Solution [PSN] · sapropterin dihydrochloride 100 MG Powder for Oral Solution [SCD] | 2 | 14 | These highlights do not include all the information needed to use S APROPTERIN DIHYDROCHLORIDE POWDER FOR ORAL SOLUTION safely and effectively. See full prescribing information for S APROPTERIN DIHYDROCHLORIDE POWDER FOR ORAL SOLUTION . SAPROPTERIN DIHYDROCHLORIDE powder for oral solution Initial U.S. Approval: 2007 | 20200709 |
| 1590afa1-baa4-70e5-5a3b-468401c71044 | sapropterin dihydrochloride 100 MG Powder for Oral Solution [PSN] · sapropterin dihydrochloride 100 MG Powder for Oral Solution [SCD] | 2 | 4 | These highlights do not include all the information needed to use JAVYGTOR safely and effectively. See full prescribing information for JAVYGTOR . JAVYGTOR TM (sapropterin dihydrochloride) powder for oral solution. Initial U.S. Approval: 2007 | 20241021 |
| 3f0d6820-ff59-40c0-882f-aeea2dd1d1ad | sapropterin dihydrochloride 100 MG Powder for Oral Solution [PSN] · sapropterin dihydrochloride 100 MG Powder for Oral Solution [SCD] | 2 | 3 | These highlights do not include all the information needed to use SAPROPTERIN DIHYDROCHLORIDE POWDER FOR ORAL SOLUTION safely and effectively. See full prescribing information for SAPROPTERIN DIHYDROCHLORIDE POWDER FOR ORAL SOLUTION. SAPROPTERIN DIHYDROCHLORIDE powder for oral solution Initial U.S. Approval: 2007 | 20260305 |
| b3999f74-920d-4444-afa7-f4211e4eb431 | sapropterin dihydrochloride 100 MG Powder for Oral Solution [PSN] · sapropterin dihydrochloride 100 MG Powder for Oral Solution [SCD] | 2 | 3 | These highlights do not include all the information needed to use SAPROPTERIN DIHYDROCHLORIDE POWDER FOR ORAL SOLUTION safely and effectively. See full prescribing information for SAPROPTERIN DIHYDROCHLORIDE POWDER FOR ORAL SOLUTION. SAPROPTERIN DIHYDROCHLORIDE powder for oral solution Initial U.S. Approval: 2007 | 20240709 |
| 39f1d020-4359-401b-88a8-ed25eaa40b45 | sapropterin dihydrochloride 100 MG Powder for Oral Solution [PSN] · sapropterin dihydrochloride 100 MG Powder for Oral Solution [SCD] | 2 | 2 | These highlights do not include all the information needed to use SAPROPTERIN DIHYDROCHLORIDE POWDER FOR ORAL SOLUTION safely and effectively. See full prescribing information for SAPROPTERIN DIHYDROCHLORIDE POWDER FOR ORAL SOLUTION. SAPROPTERIN DIHYDROCHLORIDE powder for oral solution Initial U.S. Approval: 2007 | 20260218 |
| 907e24c4-3337-4aee-b789-276e37a85cd8 | sapropterin dihydrochloride 100 MG Powder for Oral Solution [PSN] · sapropterin dihydrochloride 100 MG Powder for Oral Solution [SCD] | 2 | 1 | These highlights do not include all the information needed to use SAPROPTERIN DIHYDROCHLORIDE POWDER FOR ORAL SOLUTION safely and effectively. See full prescribing information for SAPROPTERIN DIHYDROCHLORIDE POWDER FOR ORAL SOLUTION. SAPROPTERIN DIHYDROCHLORIDE powder, for oral solution Initial U.S. Approval: 2007 | 20260114 |
| 8de84882-dd24-46f2-8416-5e492d4275d1 | sapropterin dihydrochloride 100 MG Powder for Oral Solution [PSN] · sapropterin dihydrochloride 100 MG Powder for Oral Solution [SCD] | 2 | 1 | These highlights do not include all the information needed to use ZELVYSIA safely and effectively. See full prescribing information for ZELVYSIA. ZELVYSIA TM (sapropterin dihydrochloride) powder, for oral solution Initial U.S. Approval: 2007 | 20250430 |